The uPA/uPAR system in choroidal neovascularization: A target for anti-angiogenic therapy

被引：0
|
作者：
Das, A
McGuire, PG
Jones, TR
Talarico, N
Warren, E
机构：
[1] Univ New Mexico Hlth Sci, Dept Cell Biol & Physiol, Albuquerque, NM USA
[2] Angstrom Pharmaceut, San Diego, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2003年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3941
引用
收藏
页码：U410 / U410
页数：1
相关论文
共 50 条
  • [1] The uPA/uPAR system in choroidal neovascularization: A target for anti-angiogenic therapy.
    Das, A
    McGuire, P
    Jones, TR
    Boyd, N
    Talarico, N
    Warren, E
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S89 - S89
  • [2] The uPA/uPAR system in retinal neovascularization: A target for anti-angiogenic therapy
    Mcguire, PG
    Jones, TR
    Talaric, N
    Warren, E
    Das, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U288 - U288
  • [3] Secretogranin III as a novel target for anti-angiogenic therapy of choroidal neovascularization
    Li, Wei
    LeBlanc, Michelle
    Wang, Weiwen
    Ji, Yanli
    Liu, Dachuan
    Zhang, Xuxiang
    Tian, Hong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [4] The anti-angiogenic effects of arctigenin on choroidal neovascularization pathogenesis
    Shirakawa, Aimi
    Yasuda, Hiroto
    Nakamura, Shinsuke
    Takajo, Yuichi
    Inamasu, Satoshi
    Yomoda, Satoshi
    Watanabe, Shimpei
    Kuse, Yoshiki
    Shimazawa, Masamitsu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2025, 158 (01) : 42 - 51
  • [5] Development of Anti-Angiogenic Nanoformulations for Choroidal Neovascularization Treatment
    Huang, Hsin-Wei
    Wang, Ya-Hui
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [6] The anti-angiogenic effect of arctigenin on choroidal neovascularization pathogenesis
    Shirakawa, Aimi
    Yasuda, Hiroto
    Nakamura, Shinsuke
    Takajo, Yuichi
    Inamasu, Satoshi
    Yomoda, Satoshi
    Watanabe, Shimpei
    Kuse, Yoshiki
    Shimazawa, Masamitsu
    Shirakawa, Aimi
    Yasuda, Hiroto
    Nakamura, Shinsuke
    Takajo, Yuichi
    Inamasu, Satoshi
    Yomoda, Satoshi
    Watanabe, Shimpei
    Kuse, Yoshiki
    Shimazawa, Masamitsu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [7] Anti-angiogenic Effects of Doxazosin on Experimental Choroidal Neovascularization in Mice
    Liu, Wei
    Guo, Jiaxian
    Sun, Xiaodong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [8] The Anti-angiogenic Effects of Gold Nanoparticles on Experimental Choroidal Neovascularization in Mice
    Kang, S.
    Rho, C. R.
    Cho, W. K.
    Roh, Y. J.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [9] Metabolic reprogramming as a target for anti-angiogenic therapy
    Gupta, P.
    Shukla, A.
    Singh, R.
    Mishra, D. P.
    CANCER MEDICINE, 2018, 7 : 16 - 16
  • [10] Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats
    Yafai, Yousef
    Yang, Xiu Mei
    Niemeyer, Marc
    Nishiwaki, Akiko
    Lange, Johannes
    Wiedemann, Peter
    King, Andrew G.
    Yasukawa, Tsutomu
    Eichler, Wolfram
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 666 (1-3) : 12 - 18
12345